Premium
An overview of human papillomavirus infection for the dermatologist: disease, diagnosis, management, and prevention
Author(s) -
Forcier Michelle,
Musacchio Najah
Publication year - 2010
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/j.1529-8019.2010.01350.x
Subject(s) - medicine , genital warts , dermatology , hpv infection , disease , vulvar intraepithelial neoplasia , dysplasia , natural history , human papillomavirus , vaccination , sex organ , cervical cancer , vulva , gynecology , cancer , immunology , biology , genetics
Genital human papillomavirus (HPV) is a common, usually transient, dermatologic infection transmitted by genital contact that can cause a variety of anogenital diseases, including warts (condyloma), dysplasia (cervical, vaginal, vulvar, anal), and squamous cell carcinoma. A number of treatment modalities are available to treat anogenital warts, both patient‐ and provider‐applied. Treatment is efficacious, but lesions can recur. Bivalent and quadrivalent vaccines are approved to prevent HPV infection. Both are indicated to prevent cervical cancer, while the quadrivalent vaccine is also approved to prevent vaginal/vulvar cancers as well as genital warts in males and females. Providers should clearly explain the natural history and potential sequelae of HPV disease, counsel patients on prevention strategies, and recommend vaccination as an effective method of prevention to their patients.